by FiveSenses | Jan 28, 2026 | News Release
Montreal, QC, Canada, January 28th, 2026 — Defence Therapeutics Inc. (“Defence” or the “Company”), a publicly traded biotechnology and precision intracellular drug-delivery company, today announced the strengthening of its long-standing collaboration with Canadian... 
by FiveSenses | Jan 21, 2026 | News Release
Montreal, QC, Canada, January 21st, 2026 — Defence Therapeutics Inc., (“Defence” or the “Company”), a publicly traded biotechnology company, today announced an evolution of its corporate positioning to reflect its focus as a precision intracellular drug-delivery...
Recent Comments